Michael Filbin
Overview
Explore the profile of Michael Filbin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Collins S, Shotwell M, Strich J, Gibbs K, de Wit M, Files D, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2448215.
PMID: 39625722
Importance: Fostamatinib, a spleen tyrosine kinase inhibitor, has been reported to improve outcomes of COVID-19. Objective: To evaluate the efficacy and safety of fostamatinib in adults hospitalized with COVID-19 and...
2.
Yin S, Klaeger S, Chea V, Carulli I, Rachimi S, Black K, et al.
Front Immunol
. 2023 Nov;
14:1269335.
PMID: 37942334
Introduction: Severe respiratory illness is the most prominent manifestation of patients infected with SARS-CoV-2, and yet the molecular mechanisms underlying severe lung disease in COVID-19 affected patients still require elucidation....
3.
Pham T, Zu Y, Ghamsari F, Oh J, Mauvais-Jarvis F, Zheng H, et al.
J Endocr Soc
. 2023 Mar;
7(5):bvad029.
PMID: 36911320
Context: Metabolic syndrome (MetS) is associated with increased risk of severe COVID-19. MetS inflammatory biomarkers share similarities with those of COVID-19, yet this association is poorly explored. Objective: Biomarkers of...
4.
Rhee C, Filbin M, Klompas M
Clin Infect Dis
. 2023 Feb;
76(12):2056-2058.
PMID: 36804679
No abstract available.
5.
Parthasarathy U, Kuang Y, Thakur G, Hogan J, Wyche T, Norton Jr J, et al.
iScience
. 2023 Feb;
26(2):105948.
PMID: 36756375
Sepsis is a life-threatening condition caused by a dysregulated host response to infection. Despite continued efforts to understand the pathophysiology of sepsis, no effective therapies are currently available. While singular...
6.
Lee A, McEvoy D, Stump T, Stevens R, Deng H, Rubins D, et al.
Ann Emerg Med
. 2023 Jan;
81(4):485-491.
PMID: 36669909
Study Objective: Delays in the second dose of antibiotics in the emergency department (ED) are associated with increased morbidity and mortality in patients with serious infections. We analyzed the influence...
7.
Junqueira C, Crespo A, Ranjbar S, Lewandrowski M, Ingber J, de Lacerda L, et al.
Res Sq
. 2021 Aug;
PMID: 34401873
SARS-CoV-2 causes acute respiratory distress that can progress to multiorgan failure and death in a minority of patients. Although severe COVID-19 disease is linked to exuberant inflammation, how SARS-CoV-2 triggers...
8.
Albala L, Loesche M, Hayes B, McEvoy D, Filbin M, Dutta S, et al.
Am J Emerg Med
. 2021 Jun;
49:294-299.
PMID: 34182272
Background: The impact of alcohol or opioid use disorders on medication dosing for procedural sedation in the emergency department (ED) is unclear, as most of the literature is from gastrointestinal...
9.
Kaplonek P, Wang C, Bartsch Y, Fischinger S, Gorman M, Bowman K, et al.
bioRxiv
. 2021 May;
PMID: 34013263
The introduction of vaccines has inspired new hope in the battle against SARS-CoV-2. However, the emergence of viral variants, in the absence of potent antivirals, has left the world struggling...
10.
Junqueira C, Crespo A, Ranjbar S, Ingber J, Parry B, Ravid S, et al.
medRxiv
. 2021 Mar;
PMID: 33758872
One Sentence Summary: Antibody-mediated SARS-CoV-2 infection of monocytes activates inflammation and cytokine release.